Status:
COMPLETED
Cambodia Integrated HIV and Drug Prevention Implementation Program
Lead Sponsor:
University of California, San Francisco
Conditions:
HIV
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
HIV risk among female entertainment and sex workers (FESW) remains high and use of amphetamine-type stimulants (ATS) significantly increases this risk. We designed a cluster randomized stepped wedge t...
Detailed Description
The CIPI Study is 16-week program that combines Conditional Cash Transfer (CCT) and group-based supportive After Care (AC) for moderate and high risk FESW ATS users using a stepped wedge randomized cl...
Eligibility Criteria
Inclusion
- 18 years of age or older
- biological female
- speaks Khmer language
- self reports 2 or more sex partners and/or transactional sex in last month
- able to provide informed consent
Exclusion
- male sex
- under 18 years of age
- unable to speak Khmer language
- unable to consent
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1198 Patients enrolled
Trial Details
Trial ID
NCT01835574
Start Date
April 1 2013
End Date
December 1 2016
Last Update
May 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Family Health International
Phnom Penh, Cambodia